{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:36:55Z","timestamp":1792111015620,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:00:00Z","timestamp":1564185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:00:00Z","timestamp":1564185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004829","name":"Connecticut Innovations","doi-asserted-by":"publisher","award":["517"],"award-info":[{"award-number":["517"]}],"id":[{"id":"10.13039\/100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12974-019-1540-2","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T05:02:44Z","timestamp":1564203764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Systemic TLR2 tolerance enhances central nervous system remyelination"],"prefix":"10.1186","volume":"16","author":[{"given":"Nicholas J.","family":"Wasko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan Horne","family":"Kulak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debayon","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Nicaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank C.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal M.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Pachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7660-5263","authenticated-orcid":false,"given":"Robert B.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,27]]},"reference":[{"issue":"6","key":"1540_CR1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jnr.24090","volume":"96","author":"Heather Yong","year":"2017","unstructured":"Yong H, Chartier G, Quandt J. Modulating inflammation and neuroprotection in multiple sclerosis. J Neurosci Res. 2018;96(6):927\u201350.","journal-title":"Journal of Neuroscience Research"},{"issue":"3","key":"1540_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nrneurol.2015.14","volume":"11","author":"RM Ransohoff","year":"2015","unstructured":"Ransohoff RM, Hafler DA, Lucchinetti CF. Multiple sclerosis-a quiet revolution. Nat Rev Neurol. 2015;11(3):134\u201342.","journal-title":"Nat Rev Neurol"},{"issue":"23","key":"1540_CR3","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.febslet.2011.03.048","volume":"585","author":"KA Hanafy","year":"2011","unstructured":"Hanafy KA, Sloane JA. Regulation of remyelination in multiple sclerosis. FEBS Lett. 2011;585(23):3821\u20138.","journal-title":"FEBS Lett"},{"issue":"1","key":"1540_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s13311-015-0409-z","volume":"13","author":"A Shirani","year":"2016","unstructured":"Shirani A, Okuda DT, Stuve O. Therapeutic advances and future prospects in progressive forms of multiple sclerosis. Neurotherapeutics. 2016;13(1):58\u201369.","journal-title":"Neurotherapeutics."},{"issue":"1","key":"1540_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2008.05570.x","volume":"107","author":"DM McTigue","year":"2008","unstructured":"McTigue DM, Tripathi RB. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem. 2008;107(1):1\u201319.","journal-title":"J Neurochem"},{"issue":"11","key":"1540_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008;9(11):839\u201355.","journal-title":"Nat Rev Neurosci"},{"issue":"6106","key":"1540_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1126\/science.1218071","volume":"338","author":"SA Goldman","year":"2012","unstructured":"Goldman SA, Nedergaard M, Windrem MS. Glial progenitor cell-based treatment and modeling of neurological disease. Science. 2012;338(6106):491\u20135.","journal-title":"Science."},{"issue":"4","key":"1540_CR8","first-page":"602","volume":"69","author":"D Kremer","year":"2011","unstructured":"Kremer D, Aktas O, Hartung HP, Kury P. The complex world of oligodendroglial differentiation inhibitors. AnnNeurol. 2011;69(4):602\u201318.","journal-title":"AnnNeurol."},{"issue":"Pt 7","key":"1540_CR9","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1093\/brain\/awn096","volume":"131","author":"T Kuhlmann","year":"2008","unstructured":"Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain. 2008;131(Pt 7):1749\u201358.","journal-title":"Brain."},{"issue":"6","key":"1540_CR10","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.4049\/jimmunol.1600876","volume":"197","author":"EJ Anstadt","year":"2016","unstructured":"Anstadt EJ, Fujiwara M, Wasko N, Nichols F, Clark RB. TLR tolerance as a treatment for central nervous system autoimmunity. J Immunol. 2016;197(6):2110\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"1540_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/medsci6030069","volume":"6","author":"Trevor Kirby","year":"2018","unstructured":"Kirby TO, Ochoa-Reparaz J. The gut microbiome in multiple sclerosis: a potential therapeutic avenue. Med Sci (Basel). 2018;6(3). \n                              https:\/\/doi.org\/10.3390\/medsci6030069\n                              \n                           . Review. PMID:30149548","journal-title":"Medical Sciences"},{"key":"1540_CR12","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1038\/ncomms5432","volume":"5","author":"Y Wang","year":"2014","unstructured":"Wang Y, Telesford KM, Ochoa-Reparaz J, Haque-Begum S, Christy M, Kasper EJ, et al. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat Commun. 2014;5:4432.","journal-title":"Nat Commun"},{"issue":"8","key":"1540_CR13","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1007\/s12035-017-0838-2","volume":"55","author":"S Esser","year":"2018","unstructured":"Esser S, Gopfrich L, Bihler K, Kress E, Nyamoya S, Tauber SC, et al. Toll-like receptor 2-mediated glial cell activation in a mouse model of Cuprizone-induced demyelination. Mol Neurobiol. 2018;55(8):6237\u201349.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1540_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s10020-018-0052-3","volume":"24","author":"G Gyetvai","year":"2018","unstructured":"Gyetvai G, Roe C, Heikal L, Ghezzi P, Mengozzi M. Leukemia inhibitory factor inhibits erythropoietin-induced myelin gene expression in oligodendrocytes. Mol Med. 2018;24(1):51.","journal-title":"Mol Med"},{"issue":"25","key":"1540_CR15","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1073\/pnas.1006496107","volume":"107","author":"JA Sloane","year":"2010","unstructured":"Sloane JA, Batt C, Ma Y, Harris ZM, Trapp B, Vartanian T. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci U S A. 2010;107(25):11555\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1540_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2013.11","volume":"2","author":"V Farrokhi","year":"2013","unstructured":"Farrokhi V, Nemati R, Nichols FC, Yao X, Anstadt E, Fujiwara M, et al. Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis. Clin Transl Immunology. 2013;2(11):e8.","journal-title":"Clin Transl Immunology"},{"issue":"3","key":"1540_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/cei.13150","volume":"193","author":"M Fujiwara","year":"2018","unstructured":"Fujiwara M, Anstadt EJ, Flynn B, Morse K, Ng C, Paczkowski P, et al. Enhanced TLR2 responses in multiple sclerosis. Clin Exp Immunol. 2018;193(3):313\u201326.","journal-title":"Clin Exp Immunol"},{"issue":"26","key":"1540_CR18","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1523\/JNEUROSCI.0219-10.2010","volume":"30","author":"S Goebbels","year":"2010","unstructured":"Goebbels S, Oltrogge JH, Kemper R, Heilmann I, Bormuth I, Wolfer S, et al. Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J Neurosci. 2010;30(26):8953\u201364.","journal-title":"J Neurosci"},{"key":"1540_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainres.2018.03.018","volume":"1689","author":"J Roy","year":"2018","unstructured":"Roy J. Primary microglia isolation from mixed cell cultures of neonatal mouse brain tissue. Brain Res. 2018;1689:21\u20139.","journal-title":"Brain Res"},{"issue":"3","key":"1540_CR20","first-page":"133","volume":"12","author":"AE Medvedev","year":"2006","unstructured":"Medvedev AE, Sabroe I, Hasday JD, Vogel SN. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res. 2006;12(3):133\u201350.","journal-title":"J Endotoxin Res"},{"issue":"6","key":"1540_CR21","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1074\/jbc.M508125200","volume":"281","author":"K Chen","year":"2006","unstructured":"Chen K, Iribarren P, Hu J, Chen J, Gong W, Cho EH, et al. Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J Biol Chem. 2006;281(6):3651\u20139.","journal-title":"J Biol Chem"},{"issue":"20","key":"1540_CR22","doi-asserted-by":"publisher","first-page":"14975","DOI":"10.1074\/jbc.M607277200","volume":"282","author":"D Kim","year":"2007","unstructured":"Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, et al. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem. 2007;282(20):14975\u201383.","journal-title":"J Biol Chem"},{"issue":"6","key":"1540_CR23","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","volume":"173","author":"JK Olson","year":"2004","unstructured":"Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 2004;173(6):3916\u201324.","journal-title":"J Immunol"},{"key":"1540_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","volume":"11","author":"JD Cherry","year":"2014","unstructured":"Cherry JD, Olschowka JA, O'Banion MK. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation. 2014;11:98.","journal-title":"J Neuroinflammation"},{"key":"1540_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pharmthera.2015.06.010","volume":"154","author":"Y Nakagawa","year":"2015","unstructured":"Nakagawa Y, Chiba K. Diversity and plasticity of microglial cells in psychiatric and neurological disorders. Pharmacol Ther. 2015;154:21\u201335.","journal-title":"Pharmacol Ther"},{"issue":"9","key":"1540_CR26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci. 2013;16(9):1211\u20138.","journal-title":"Nat Neurosci"},{"key":"1540_CR27","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3389\/fimmu.2018.01202","volume":"9","author":"T Zhou","year":"2018","unstructured":"Zhou T, Huang Z, Zhu X, Sun X, Liu Y, Cheng B, et al. Alpha-1 antitrypsin attenuates M1 microglia-mediated neuroinflammation in retinal degeneration. Front Immunol. 2018;9:1202.","journal-title":"Front Immunol"},{"issue":"2","key":"1540_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.14336\/AD.2017.0328","volume":"9","author":"Z Han","year":"2018","unstructured":"Han Z, Zhao H, Tao Z, Wang R, Fan Z, Luo Y, et al. TOPK promotes microglia\/macrophage polarization towards M2 phenotype via inhibition of HDAC1 and HDAC2 activity after transient cerebral ischemia. Aging Dis. 2018;9(2):235\u201348.","journal-title":"Aging Dis"},{"issue":"10","key":"1540_CR29","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.4049\/jimmunol.178.10.6173","volume":"178","author":"Y Yanagawa","year":"2007","unstructured":"Yanagawa Y, Onoe K. Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation. J Immunol. 2007;178(10):6173\u201380.","journal-title":"J Immunol"},{"issue":"2","key":"1540_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1189\/jlb.2A0515-197R","volume":"100","author":"MA Nahid","year":"2016","unstructured":"Nahid MA, Benso LM, Shin JD, Mehmet H, Hicks A, Ramadas RA. TLR4, TLR7\/8 agonist-induced miR-146a promotes macrophage tolerance to MyD88-dependent TLR agonists. J Leukoc Biol. 2016;100(2):339\u201349.","journal-title":"J Leukoc Biol"},{"key":"1540_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnmol.2015.00021","volume":"8","author":"A Abbasi","year":"2015","unstructured":"Abbasi A, Forsberg K, Bischof F. The role of the ubiquitin-editing enzyme A20 in diseases of the central nervous system and other pathological processes. Front Mol Neurosci. 2015;8:21.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"1540_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jneuroim.2008.06.034","volume":"203","author":"MM Hiremath","year":"2008","unstructured":"Hiremath MM, Chen VS, Suzuki K, Ting JP, Matsushima GK. MHC class II exacerbates demyelination in vivo independently of T cells. J Neuroimmunol. 2008;203(1):23\u201332.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1540_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001;11(1):107\u201316.","journal-title":"Brain Pathol"},{"issue":"5","key":"1540_CR34","doi-asserted-by":"publisher","first-page":"175909141455195","DOI":"10.1177\/1759091414551955","volume":"6","author":"Hilary H. Sachs","year":"2014","unstructured":"Sachs HH, Bercury KK, Popescu DC, Narayanan SP, Macklin WB. A new model of cuprizone-mediated demyelination\/remyelination. ASN Neuro. 2014;6(5). \n                              https:\/\/doi.org\/10.1177\/1759091414551955\n                              \n                           . 2014. PMID:25290063","journal-title":"ASN Neuro"},{"key":"1540_CR35","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3389\/fimmu.2017.01520","volume":"8","author":"SA Amici","year":"2017","unstructured":"Amici SA, Dong J, Guerau-de-Arellano M. Molecular mechanisms modulating the phenotype of macrophages and microglia. Front Immunol. 2017;8:1520.","journal-title":"Front Immunol"},{"key":"1540_CR36","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","volume":"5","author":"M Rath","year":"2014","unstructured":"Rath M, Muller I, Kropf P, Closs EI, Munder M. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages. Front Immunol. 2014;5:532.","journal-title":"Front Immunol"},{"issue":"2","key":"1540_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/jnc.12705","volume":"130","author":"VE Miron","year":"2014","unstructured":"Miron VE, Franklin RJ. Macrophages and CNS remyelination. J Neurochem. 2014;130(2):165\u201371.","journal-title":"J Neurochem"},{"key":"1540_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fncel.2018.00178","volume":"12","author":"N Laflamme","year":"2018","unstructured":"Laflamme N, Cisbani G, Prefontaine P, Srour Y, Bernier J, St-Pierre MK, et al. mCSF-induced microglial activation prevents myelin loss and promotes its repair in a mouse model of multiple sclerosis. Front Cell Neurosci. 2018;12:178.","journal-title":"Front Cell Neurosci"},{"key":"1540_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.conb.2017.10.001","volume":"47","author":"AF Lloyd","year":"2017","unstructured":"Lloyd AF, Davies CL, Miron VE. Microglia: origins, homeostasis, and roles in myelin repair. Curr Opin Neurobiol. 2017;47:113\u201320.","journal-title":"Curr Opin Neurobiol"},{"issue":"5","key":"1540_CR40","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1046\/j.1471-4159.2003.02087.x","volume":"87","author":"MA Ajmone-Cat","year":"2003","unstructured":"Ajmone-Cat MA, Nicolini A, Minghetti L. Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. J Neurochem. 2003;87(5):1193\u2013203.","journal-title":"J Neurochem"},{"key":"1540_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnmol.2015.00035","volume":"8","author":"A Alizadeh","year":"2015","unstructured":"Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Myelin damage and repair in pathologic CNS: challenges and prospects. Front Mol Neurosci. 2015;8:35.","journal-title":"Front Mol Neurosci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1540-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T23:09:55Z","timestamp":1595718595000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1540-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1540"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1540-2","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,27]]},"assertion":[{"value":"4 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All mice were maintained under specific pathogen-free conditions in accordance with the guidelines for the Center for Comparative Medicine at UConn Health. All procedures were performed in compliance with Institutional Animal Care and Use Committee-approved protocols.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}